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Background: The aim of this study is to validate the pattern identiﬁcation standard of qi,
blood, yin, and yang deﬁciency patterns diagnosis. The current study will investigate the
usefulness of the Qi Blood Yin Yang deﬁciency pattern questionnaire as a diagnostic tool for
qi, blood, yin, and yang deﬁciencies by assessing the agreement between the scores and a
gold standard established by assessors.
Methods: This protocol is for a single center, prospective, observational study. A total of
248 eligible patients with unexplained chronic fatigue will be assigned to four groups in a
1:1:1:1 ratio as the qi deﬁciency group, blood deﬁciency group, yin deﬁciency group, and yang
deﬁciency group. The primary outcomewill be measured using the score of the Qi Blood Yin
Yang deﬁciency pattern questionnaire and the secondary outcomes will be measured using
the fatigue severity scale, Korean-translated chalder fatigue scale, computerized tongue
image analysis system, and three types of pattern identiﬁcation questionnaires (cold-heat,
food accumulation, and seven emotions patterns). The safety of the clinical study will be
assessed after measurements at every visit. All statistical analysis will be performed using
the R Statistics program. Statistics experts will analyze the relationship between clinical
data using the Pearson’s Chi-squared test and independent t-test.
Discussion: This study will provide reference data and good evidence that are applicable
to future studies. Furthermore, the results of the present study are useful to improve thecare of patients with unexplained chronic fatigue and unexplained chronic fatigue-related
disorders.
© 2015 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access∗ Corresponding author. KM Fundamental Research Division, Korea I
aejeon, 34054, Republic of Korea.
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1. Background
Chronic fatigue (CF) generally refers to the status of sub-
jective tiredness or to a lack of energy. CF is divided into
explained CF and unexplained chronic fatigue (UCF) for which
no medical explanation exists. UCF is classiﬁed as chronic
fatigue syndrome (CFS) or idiopathic chronic fatigue (ICF).1
The diagnostic criteria for CFS are as follows: (1) duration
of severe fatigue > 6 months; (2) other causes should be
excluded; and (3) the individual concurrently has four or
more of eight speciﬁc symptoms. These symptoms include
the following: (1) headache; (2) migratory polyarthralgias; (3)
myalgia; (4) postexertional malaise or fatigue (duration >
24hours); (5) impaired short-term memory or concentration;
(6) pharyngitis; (7) tender cervical or axillary adenopathy; and
(8) nonrestorative sleep. Information about CFS can be found
at http://www.cdc.gov/cfs/case-deﬁnition/index.html. Cases
that cannot be categorized according to the above diagnostic
criteria are included under ICF.
Several hypotheses have been proposed for the
pathogenesis of UCF, including oxidative stress,
hypothalamic–pituitary–adrenal axis abnormalities, and
immune dysfunction.2–4 Despite the universality of UCF, the
etiology, pathophysiology, nomenclature, and diagnostic cri-
teria of UCF still remain unclear in the medical community,5,6
and conventional medicine causes many side effects.6 As a
result, patients with UCF are greatly interested in comple-
mentary and alternative medicine and traditional Korean
Medicine (KM) based on symptomatic treatment.7
Similar to conventional medicine, in KM the clinical signs
and symptoms are collected from the patients and interpreted
to diagnose disease. However, KM practitioners diagnose
diseases and prescribe treatments in terms of individual pat-
terns of a syndrome, reﬂecting an individual’s overall body
condition.8 Syndromes can be described as the pathologi-
cal characteristics that an individual presents in response
to pathogens, allergens, or other undesirable stimulation,
whereas body constitution is used to describe one’s overall
physical and psychological condition. An individual body con-
stitution and the current health status can be considered in
terms of the balance between the qi and blood conditions of
the internal organ functions and of the coexisting yin and
yang.8,9 The ultimate objective of diagnosis and treatments
from the KM viewpoint is to help the individual recover bal-
ance of the four essential components of the human body,
including qi, blood, yin and yang.
Similarly, UCFpatients canbe classiﬁed intodeﬁciency syn-
drome or excess syndrome, which refers to the deﬁciency or
excess in qi, blood, yin, and yang.10,11 Previous studies men-
tioned that UCF is mainly considered to exhibit the deﬁciency
pattern and therefore most patients are treated by invigorat-
ing qi and yang and nourishing blood and yin.10,12 Treatments
for peoplewith UCF can be prescribed in consideration of their
patterns of body constitution; most patients have been iden-
tiﬁed as having four pattern identiﬁcations (PIs) as follows:
qi deﬁciency (QD), blood deﬁciency (BD), yin deﬁciency (YnD),
and yang deﬁciency (YgD). Patients with UCF can receive spe-
ciﬁc medicinal treatments based on the deﬁciency patterns
described above. Generally, the balance of qi, blood, yin, andIntegr Med Res ( 2 0 1 5 ) 249–255
yang is important for maintaining health and treating the
diseases in KM clinics. However, no diagnostic tools, such as
questionnaires ormedical devices, have beenvalidated in clin-
ical trials.
Therefore, the aim of this study is to validate the Qi Blood
Yin Yang deﬁciency pattern questionnaire (QBYY-Q) through a
clinical study to determine the correlations between UCF and
responses to the QBYY-Q.
2. Methods
2.1. Study design
This study will be conducted as a single center, prospective,
observational study. This clinical study will consist of screen-
ing (Visit 1), Measurement 1 (Visit 2), Measurement 2 (Visit
3,) and follow up (selected participants only). After partici-
pants complete the ﬁrst measurement, eligible participants
will be randomly selected for evaluating the test–retest relia-
bility (repeatability) of the QBYY-Q. Thirty participants will be
selected from the randomization list. A computer-generated,
blocked random allocation sequence will be generated using
a Microsoft Ofﬁce Excel program (Excel 2013, Microsoft Ofﬁce,
USA) produced by the Korean Institute of Oriental Medicine,
Daejeon, Republic of Korea. Random allocation will be per-
formed after the ﬁrst measurement of the participants who
provide informed consent andmeet the inclusion criteria. The
selected participants will complete the QBYY-Q, pattern iden-
tiﬁcation questionnaire (PI-Q), and fatigue questionnaire, and
their tongue images will be captured using the Computerized
tongue image analysis system within 3–5 weeks after Visit 2
(the ﬁrst measurement). A ﬂow diagram and study schedule
for participants are depicted in Fig. 1 and Table 1.
CDC, Centers for Disease Control and Prevention; CFS,
chronic fatigue syndrome; FSS, Fatigue Severity Scale; ICF,
idiopathic chronic fatigue; KMD, Koreanmedical doctors; PSS-
10item, Perceived Stress Scale-10item.
2.2. Recruitment of participants
2.2.1. Recruitment strategies
There will be three strategies in participant recruitment.
Firstly, participants will be recruited by advertising on hospi-
tal websites and posters displayed in Won Kwang University,
Gwangju Korean Medical Hospital. Secondly, printed recruit-
ment posters will be distributed in public clinics and nearby
communities. Thirdly, advertisements will be published in the
local universities.
2.2.2. Participants
A total of 311 participants will be enrolled in this study. The
participants that are residing in Gwangju will include 248 UCF
patients and 63 control participants. They will go through
telephone prescreening led by the clinical study coordinator,
to ensure UCF patients meet the inclusion criteria: “men and
women aged 20 years to 69 years” and “the presence of UCF
that is continuous and repetitive for more than 6 months.”
The next step is for participants to visit the clinical study
center and to undergo a more indepth screening process to
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Fig. 1 – Study schedule for participants. Participants with a diagnosis of unexplained chronic fatigue were recruited at the
Won Kwang University of Traditional Korean Medicine. A total of 248 patients were enrolled to four groups: qi deﬁciency
group A, blood deﬁciency group B, yin deﬁciency C, and yang deﬁciency D in a 1:1:1:1 ratio. The outcome was measured at
every visit.
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.2.2.1. Inclusion criteria. Participants who meet the follow-
ng criteria will be included: (1) men andwomen aged 20 years
o 69 years; (2) the presence of UCF that has been continuous
or > 6months; (3) UCF (including CFS and ICF); (4) participants
n agreement with the Korean medical doctors’ (KMDs) diag-
oses; and (5) those who consent to participate in this trial
nd who sign an informed consent statement after listening
o a clear explanation of the purpose and characteristics of
his study..2.2.2. Exclusion criteria. Participants with one or more of
he following criteria will be excluded: (1) score ≥ 14 in the
erceived Stress Scale-10item; (2) patients in disagreement
ith KMDs’ diagnoses; (3) the presence of the followingconditions in the participant’s past history that might trigger
CF: (a) organic causes, such as acute or chronic liver disease
(e.g., hepatitis, liver cirrhosis), anemia, tuberculosis, chronic
lung disease, cardiovascular disease (e.g., heart failure, hyper-
tension), endocrine/metabolic disease (e.g., diabetes, thyroid
gland disease, severe obesity), autoimmune disease (e.g.,
rheumatoid arthritis, systemic lupus erythematosus, mul-
tiple sclerosis), malignant tumors, or infectious disease; (b)
psycho-social causes, such as depression, anxiety neurosis,
recent severe stress, schizophrenia, alcoholism, or an eating
disorder (anorexia nervosa, bulimia nervosa); (4) participants
who have taken the following drugs within the past 2 weeks:
antihypertensive drugs, antidepressants, antianxiety agents,
hypnotics, or antihistamines; (5) pregnant or breast-feeding
women; (6) individuals participating in other clinical trials;
(7) individuals who are overworked; (8) individuals who
experienced a hypersensitive reaction after clinical laboratory
Fatigue Scale and the Fatigue Severity Scale, that enquires
about the participant’s current fatigue status.18,19 The Korean-
translated Chalder Fatigue Scale comprises seven physical252
test; (9) individuals who did not provide informed consent;
and (10) others whose clinical trial conductors are considered
inappropriate for participating in this study.7
2.2.2.3. Withdrawal criteria. Participants having one or more
of the withdrawal criteria will be excluded as follows: (1) intol-
erance to worsening conditions; (2) quitting voluntarily; and
(3) adverse medical events occurring during the study. If par-
ticipants withdraw from the study either in the measurement
or in the follow-up phase, the reason of withdrawal should be
clariﬁed and the rate should be statistically analyzed.
2.2.3. Sample size
Sample size calculation was based on the average effect sizes
in one previous clinical trial of QBYY-Q for patientswithUCF.13
With the level of statistical signiﬁcance set at p = 0.05 and a
study power of 90%, an estimated sample size was 56 partici-
pants per patient group and 56 participants per control group
(total 280 participants). Considering a drop-out rate of 10%, the
total sample size required is 311 (62 participants per patient
group and 63 participants control group).
2.3. Diagnostic criteria
2.3.1. Diagnosis of UCF
Diagnosis of UCF occurs in mainly patients who have suf-
fered from fatigue lasting>6 months. The Centers for Disease
Control and Prevention - 1994 criteria for CFS were used to
distinguish between CFS and ICF, using the cutoff of four
among the eight symptoms in the minor criteria, respectively.
CFS patients should complain of major criteria symptoms
and more than four of the minor criteria symptoms, and
ICF patients should complain of major criteria symptoms
but less than four of the minor criteria symptoms. If a
patient complains of fatigue lasting>6months, headache, and
pharyngitis, the patient is diagnosed as ICF.14
2.3.2. Diagnosis of PI
To date, there is no gold standard for the diagnosis of PI,
although much of the KM literature has described common
aspects of PI. Ourprevious studyalsodemonstrateddiscrepan-
cies in the diagnoses of QD, BD, YnD, and YgD among KMDs.13
To increase the internal consistency of KMD diagnosis, we cre-
ated PI guidelines for QD, BD, YnD, and YgD with KM experts.
Firstly, both conventional medicine and KM principles were
considered. Secondly, the PI guideline was designed according
to Donguibogam, KM textbook and results of a previous study.
Thirdly, the PI guideline was modiﬁed to ﬁt this study, which
was based on the advice of the experts in this ﬁeld. In addition,
a modiﬁed PI guideline was revised through the consensus of
the experts in this ﬁeld. Based on the PI guidelines, threeKMDs
with 8 years of clinical experience independentlywill diagnose
the participants’ deﬁciency PI status. Participants for which
the KMD diagnoses disagreed will be excluded from analysis.
2.4. Measurements2.4.1. Primary outcome
The QBYY-Q scores after two measurement sessions will be
used as the primary endpoint. The QBYY-Q includes 32 ques-
tions, scored on a scale of 1–4, which will be used to evaluateIntegr Med Res ( 2 0 1 5 ) 249–255
theparticipant’s qi, blood, yin, andyangdeﬁciency level during
Visit 2 and Visit 3.
2.4.2. Secondary outcome
2.4.2.1. CTIS. The CTIS consists of a lighting part, image
acquisition part, tongue positioning part, data process-
ing part, and a results display part. In particular, the
software of CTIS was developed to analyze the CIE
L*a*b*(https://en.wikipedia.org/wiki/Lab color space) of the
tongue body and coating from the captured tongue image.
The components and image analysis of CTIS were previously
described in detail (Fig. 2).15
2.4.2.2. PI-Qs. This study uses three types of PI-Qs such as: (1)
cold-heat; (2) food accumulation, and (3) seven emotions pat-
terns. The validity and reliability of all PI questionnaires will
be evaluated. The total score of each PI questionnaire will be
calculated by summing up the items. A cold-heat PI-Q, con-
sisting of 20 questions covering the following two categories,
will be used to evaluate cold pattern and heat pattern. Each
item is scored on a 7-point scale from 1 to 7.16 A food accu-
mulation PI-Q consisting of 17 questions will assess the food
accumulation. Each item is rated on a 7-point Likert scale:
1 = disagree very strongly; 2 =disagree strongly; 3 =disagree;
4 =neither agree nor disagree; 5 =agree; 6 =agree strongly; and
7=agree very strongly.4 A seven emotions PI-Q, consisting of
18 items, will be used to evaluate seven emotions as follows:
joy, anger, thought, anxiety, sorrow, fear, and fright.17
2.4.2.3. Fatigue questionnaires. To assess fatigue severity, a
numerical rating scalewill be used. The numerical rating scale
scores are measured using the Korean-translated ChalderFig. 2 – Photograph of the scene of acquisition of the
tongue image.
J. Kim and K.H. Kim/Qi Blood Yin Yang deﬁciency 253
Table 1 – Study design schedule
Period Screening Measurement 1 Measurement 2
Informed consent •
Inclusion and exclusion criteria •
Characteristics information •
Vital signs • •
Medical history •
Diagnosis of PI •
Diagnosis of chronic fatigue •
PSS •
QBYY-Q • •
PI-Q • •
FSS • •
CFS • •
Laboratory test •
Acquisition of tongue image • •
Patient’s compliance • • •
Adverse event • • •
•: Item has to be carried out for the visit in all participations.
(1) Check the inclusion and exclusion criteria; (2) characteristics information: age, sex, date of birth, smoking, alcohol, caffeine, disease history,
surgery history, drug taking, menstrual period, etc.; (3) vital signs: height, weight, temperature, systolic and diastolic pressure; (4) diagnosis
of following pattern identiﬁcation of patients: qi deﬁciency, blood deﬁciency, yin Deﬁciency, and yang deﬁciency; (5) All laboratory test results
should be interpreted within the normal reference values. Laboratory test: blood test (complete blood cell count, white blood cells, differential
cell count, erythrocyte sedimentation rate, alkaline phosphatase, aspartate transaminase, alanine transaminase, protein, albumin, blood urea
nitrogen, creatinine, gamma-glutamyl transferase, total bilirubin, direct bilirubin, uric acid, C-reactive protein, sodium, potassium, chloride,
thyroid stimulating hormone) and urinalysis (pH, speciﬁc gravity, protein, glucose, ketone, bilirubin, urobilinogen, nitrite, urine micro red blood
cells, white blood cells); (6) acquisition of tongue image by computerized tongue image analysis system; (7) check whether participation is
enrolled or not by interview and case report form; and (8) medical examination by interview and self-report of adverse event.
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TCFS, chronic fatigue syndrome; FSS, Fatigue Severity Scale; PI, pattern
accumulation and seven emotions patterns); PSS, Perceived Stress Sc
ealth (ﬁrst to seventh) and four mental health (eight to
leventh) questions. The participants will be asked to select
he score that represented the level of their own fatigue. Each
tem is scored on a 4-point scale from 0 to 3. The Fatigue Sever-
ty Scale (FSS) consisting of nine questions is one of the best
nown and most used fatigue scales. Each item is scored by
he patient on a 5-point scale (0 =not at all to 4=unbearably
evere condition).
.5. Follow up
he follow-up assessment is designed to evaluate the
est–retest reliability of QBYY-Q. Upon completion of the ﬁrst
easurement, follow-up assessments will be conducted after
–5 weeks. In addition, patients will keep the precautions
hen attending this study and complete the QBYY-Q, PI-Q,
nd CTIS measurements in the follow-up period. Patients will
end the relevant information to researchers immediately. To
ncourage participant compliance, we will show special solic-
tude for every participant and closely monitor the evolution
f their illness. The measured QBYY-Q scores at Visit 2 and
isit 3 will be compared between the ﬁrst measurement and
econd measurement..6. Randomization and blinding
his is a nonrandomized and nonblinded study.tiﬁcation; PI-Q, pattern identiﬁcation questionnaires (cold-heat, food
BYY-Q, Qi Blood Yin Yang deﬁciency questionnaire
2.7. Safety monitoring
Possible adverse events (AEs) due to laboratory tests and
tongue image acquisition include burns, electric shock, and
infection. All unexpected and unintended responses will be
reported as AEs by the researcher at every visit, even if they are
not necessarily related to this study. The AEs will be carefully
recorded in the case report form (CRF) by the corresponding
research staff.
2.8. Quality control and monitoring
Sponsor monitoring will be performed by highly trained
monitoring staff throughout the trial. All staff who sponsor,
assistants, principal researcher, assessors, and coordinators
must attend training to make sure all practices according to
the standard operating procedures. In addition, all researchers
must understand the purpose and process of this study. A
sponsor will visit once-a-month to check the compliance
with standard operating procedures regularly. Report of audits
should be presented to the chief monitor.
2.9. Data managementNo record can be missed or omitted in the original data
source. Every correction should be explained in the appended
notes, signed, and dated by the physicians participating
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in the clinical trial; primary entries are not allowed to be
changed. After the observation of a clinical case, CRF ﬁles
will be submitted to the project directors for veriﬁcation and
signed by supervisors. Data input will be done separately
by two data collectors with computers and locked once the
checking work is done. The data manager will clarify all the
questions regarding the CRF with the researchers through
clinical supervisors. Researchers should answer all questions
as soon as possible so that the data manager can conduct the
modiﬁcation, validation, and entry of the data.
2.10. Statistical analysis
Descriptive statistics will be performed using R software, ver-
sion 3.1.1, on a Windows 7 platform (R Development Core
Team. Auckland, New Zealand). The level of signiﬁcance is set
to p<0.05 for all the analyses. An investigator will survey the
demographic characteristics, UCF types, and deﬁciency types
ofUCFpatients and controls. Statistics expertswill analyze the
relationship between results using the Pearson’s Chi-squared
test and independent t-test in the R Statistics program.
2.11. Ethics
This study is conducted according to the Declaration of
Helsinki 2008 and the regulations of the Good Clinical Prac-
tice principles in the Korea Food and Drug Administration.
This protocol was reviewed and approved by the Institutional
Review Board of the Won Kwang University, Gwangju Korean
Medical Hospital in May 2015 (approval No. 2015/3) before
the participant recruitment. This clinical study was registered
on June 15, 2015 at the Korean Clinical Trials Registry with
the identiﬁer number KCT0001521. The study was conducted
according to the principles of the Declaration of Helsinki.20
3. Discussion
UCF is a major public health problem. To date, UCF remains
unclear and has no quantitative diagnostic tools and spe-
ciﬁc treatment. KM has been widely considered an alternative
option for chronic illness in East Asia. KM was more effective
than conventional medicine in the treatment of UCF.13 Fur-
thermore, conventional medicine can cause unwanted side
effects, however, KM causes no serious side effects such
as headaches, vomiting, fever, nervousness, spontaneous
bleeding, and changes in appetite. According toKM,UCF is cat-
egorized into patterns of deﬁciency or excess. UCF is mainly
diagnosed the deﬁciency pattern, classiﬁed into qi, blood, yin,
and yang deﬁciencies, and specialized treatments are then
applied according to the particular deﬁciency patterns.10 In
general, PI diagnosis is a key tool of KM treatment and has
great curative power for many chronic illness. However, no
diagnostic tools, such as a questionnaires or medical devices,
have been validated in clinical trials. Therefore, the current
study was designed to obtain objective diagnostic tools on the
usefulness of QBYY-Q for the diagnosis of four deﬁciency pat-
terns in the UCF patients. The clinical trial protocol plays a
vital role of study conduct, reporting, and appraisal. To facil-
itate appropriate high quality methodology and strict qualityIntegr Med Res ( 2 0 1 5 ) 249–255
control, this protocol has been developed according to the pre-
vious protocol data and clinical data.
If the clinical effectiveness of QBYY-Q is veriﬁed in the
present study, it will provide reasonable evidence for pre-
scribing herbal medicine for UCF and related-UCF patients. It
could be used as a new alternative diagnostic tool in patients
with UCF, which is without established standard therapies in
conventional medicine. The current study has two potential
strengths. Firstly, it is unique and a ﬁrst attempt. Secondly, we
will determine whether the characteristics of the tongue can
change QBYY-Q scores and the subjective feeling of fatigue.
Although the relationship between a tongue diagnosis and PI
or fatigue severity is controversial, the change in these factors
associating with PI diagnosis could be compared in this study.
Firstly, our study will be conducted only in Gwangju, Korea
and, as a result, has limited population validity. Secondly, this
study has the possibility of a high risk of bias regarding diag-
nosed patients’ PI. These standards are different from the
symptoms and signs of PI, which are very difﬁcult to stan-
dardize. Further studies are considered to overcome these
limitations with respect to population validity and standard
guideline for diagnosis of PI. Large clinical trials in multiple
centers on PI and the evaluation of the therapeutic effects
on UCF in randomized clinical trials are also needed. It is
believed that this study will provide a reference data and good
evidence that are applicable to future studies. Moreover, the
results of the present study can be used to improve the care of
patients with UCF and UCF-related disorders and to facilitate
research on anti-UCF therapies using KM. The trial is currently
in the recruitment phase. Participant recruitment started in
July 2015, and is expected to end in October 2015.
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Appendix 1. Qi Blood Yin Yang deﬁciency
questionnaire.We would like to know more about any problems you have
experienced recently. Please answer all the questions by
checking the answer that applies to you most closely.
1: disagree strongly, 2: disagree, 3: agree, 4: agree strongly
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ondition 1 2 3 4
feel listless    
feel too languid to work    
feel feeling of helplessness    
attempt the impossible    
do not gain weight despite
eating fully
   
feel giddy    
y heart keeps pounding    
feel dull pain in my low back
or knee
   
feel weak and cannot move
around much
   
feel hot deep in the body,
hand, and foot
   
often have a cramp    
have a ﬂush in the afternoon    
have a pale complexion    
have a rough skin    
y hair is friable    
have a bad complexion of
lips, lids, and nail
   
have a dry and fatigue eyes    
have a failure of eyesight    
have a dry mouth    
haven’t had my appetite
lately
   
have a fever in the afternoon    
prefer warm thing to cold
thing
   
prefer warm beverages to
cold beverages
   
y hands and feet get cold    
usually sweat a lot these days    
sweat during sleep    
he voice is getting smaller    
frequently had a dream
during sleep
   
urinate frequently during
feel cold
   
have diarrhea in the dawn    
have soft stools    
have s symptoms of
proctoptosis and
hysteroptosis
   
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